Signaling Pathway
Emerfetamab is a monoclonal antibody designed to target both CD3E and CD33 molecules. This dual specificity enables it to engage T cells via CD3E and simultaneously recognize myeloid cells through CD33, making it a valuable tool in the research of immune cell interactions and potential therapeutic applications in hematological malignancies.
重要通知：仅供研究使用。我们不向患者销售。
| Discription | Emerfetamab is a monoclonal antibody designed to target both CD3E and CD33 molecules. This dual specificity enables it to engage T cells via CD3E and simultaneously recognize myeloid cells through CD33, making it a valuable tool in the research of immune cell interactions and potential therapeutic applications in hematological malignancies. |
||
|---|---|---|---|
| Targets |
|
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
